The role of national cancer institute-designated cancer center status: Observed variation in surgical care depends on the level of evidence

Annals of Surgery

Volumn 255, Issue 5, 2012, Pages 890-895

  In, Haejin ^a,b   Neville, Bridget A ^c   Lipsitz, Stuart R ^a   Corso, Katherine A ^a   Weeks, Jane C ^c   Greenberg, Caprice C ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; COLON CANCER; EVIDENCE BASED MEDICINE; HUMAN; MEDICARE; NATIONAL HEALTH ORGANIZATION; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECTUM CANCER; STOMACH CANCER; THYROID CANCER;

AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CANCER CARE FACILITIES; COLONIC NEOPLASMS; FEMALE; GUIDELINE ADHERENCE; HUMANS; LYMPH NODE EXCISION; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; RECTAL NEOPLASMS; SEER PROGRAM; STANDARD OF CARE; THYROID NEOPLASMS; UNITED STATES;

EID: 84859918508     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31824deae6     Document Type: Article

References (52)

1. Medina-Franco H, Garcia-Alvarez MN, Rojas-Garcia P, et al. Body image perception and quality of life in patients who underwent breast surgery. Am Surg. 2010;76:1000-1005.
2. National Cancer Institute Cancer Centers Program. Available at: http://cancercenters.cancer.gov/. Accessed November 30, 2010.
3. Birkmeyer NJ, Goodney PP, Stukel TA, et al. Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer. 2005;103:435-441.
4. Paulson EC, Mitra N, Sonnad S, et al. National Cancer Institute designation predicts improved outcomes in colorectal cancer surgery. Ann Surg. 2008;248:675-686.
5. Friese CR, Earle CC, Silber JH, et al. Hospital characteristics, clinical severity, and outcomes for surgical oncology patients. Surgery. 2010;147:602-609.
6. Bilimoria KY, Bentrem DJ, Linn JG, et al. Utilization of total thyroidectomy for papillary thyroid cancer in the United States. Surgery. 2007;142:906-913; discussion 913.e1-2. (Pubitemid 350184098)
7. Bilimoria KY, Talamonti MS, Wayne JD, et al. Effect of hospital type and volume on lymph node evaluation for gastric and pancreatic cancer. Arch Surg. 2008;143:671-678; discussion 678. (Pubitemid 352040238)
8. Wadman M. New plan proposed to help resolve conflicting medical advice. Nat Med. 2008;14:226. (Pubitemid 351347888)
9. Moulton G. IOM report on quality of cancer care highlights need for research, data expansion. Institute of Medicine. J Natl Cancer Inst. 1999;91:761-762.
10. Davis D, Evans M, Jadad A, et al. The case for knowledge translation: shortening the journey from evidence to effect. BMJ. 2003;327:33-35. (Pubitemid 36801894)
11. Grimshaw JM, Thomas RE,MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004;8:iii-iv, 1-72.
12. Tricoci P, Allen JM, Kramer JM, et al. Scientific evidence underlying the ACC/AHA clinical practice guidelines. JAMA. 2009;301:831-841.
13. Schroen AT, Brenin DR. Breast cancer treatment beliefs and influences among surgeons in areas of scientific uncertainty. Am J Surg. 2010;199:491-499.
14. Simunovic M, Baxter NN. Knowledge translation research: a review and new concepts from a surgical case study. Surgery. 2009;145:639-644.
15. Greenberg CC, Lipsitz SR, Neville B, et al. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011;146:1128-1134.
16. NCCNClinical PracticeGuidelines in Oncology (NCCN GuidelinesTM).Available at: http://www.nccn.org/clinical.asp. Accessed June 15, 2010.
17. Charlson ME, Pompei P,AlesKL, et al.Anewmethod of classifying prognostic comorbidity in longitudinal studies: development and validation. JChronicDis. 1987;40:373-383. (Pubitemid 17055592)
18. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45:613-619.
19. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267. (Pubitemid 32007842)
20. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757-763. (Pubitemid 27446562)
21. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11:550-560. (Pubitemid 30660034)
22. Halsted W. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1-19.
23. Brunicardi F, Anderson D, Billiar T, et al. Schwartz's Manual Of Surgery. 8th ed. New York, NY: McGraw-Hill; 2006. Available at: http://www.R2Library. com/marc frame.aspx?ResourceID=238. Accessed February 17, 2011.
24. Bilimoria KY, Bentrem DJ, Hansen NM, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for nodepositive breast cancer. J Clin Oncol. 2009;27:2946-2953.
25. Fant J, Grant M, Knox S, et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol. 2003;10:126-130. (Pubitemid 40485931)
26. Fisher B, Wolmark N, Bauer M, et al. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet. 1981;152:765-772. (Pubitemid 11072899)
27. Hwang RF, Gonzalez-Angulo AM, et al. Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection. Cancer. 2007;110:723-730. (Pubitemid 47257646)
28. Jeruss JS,Winchester D, Sener S, et al. Axillary recurrence after sentinel node biopsy. Ann Surg Oncol. 2005;12:34-40. (Pubitemid 40486639)
29. Giuliano AE,McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010;252:426-432; discussion 432-423.
30. Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis. JAMA. 2011;305:569-575.
31. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1989;95(suppl):2S-4S. (Pubitemid 19045150)
32. US Preventitive Services Task Force (USPSTF):Hierarchy of Research Design. Available at: http://www.ahrq.gov/clinic/uspstfix.htm. Accessed December 1, 2010.
33. Cooper DS, Doherty GM, Haugen BR, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1214.
34. Butler Nattinger A, Schapira MM, Warren JL, et al. Methodological issues in the use of administrative claims data to study surveillance after cancer treatment. Med Care. 2002;40(suppl):IV-69-74.
35. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31:732-748.
36. Warren JL, Klabunde CN, Schrag D, et al. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. 2002;40(suppl):IV3-18.
37. Cooper GS, Virnig B, Klabunde CN, et al. Use of SEER-Medicare data for measuring cancer surgery. Med Care. 2002;40(suppl):IV43-48.
38. American Cancer Society: Cancer Facts & Figures. Available at: http://www. cancer.org/Research/CancerFactsFigures/index. AccessedNovember 15, 2010.
39. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93:850-857. (Pubitemid 32590779)
40. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol. 2003;21:1293-1300. (Pubitemid 46606406)
41. Dobie SA, Baldwin LM, Dominitz JA, et al. Completion of therapy by Medicare patients with stage III colon cancer. J Natl Cancer Inst. 2006;98:610-619. (Pubitemid 43904844)
42. Luo R, Giordano SH, Zhang DD, et al. The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist. Cancer. 2007;109:975-982. (Pubitemid 46333539)
43. Brant-Zawadzki M, Wortham J, Cox J. Search for meaning: centers of excellence, service lines and institutes. Physician Exec. 2009;35:32-34, 36-37.
44. Cress D, Pelton J, Thayer SC, et al. Development of a center of excellence for joint replacement. Orthop Nurs. 2010;29:150-168.
45. Meyer LC. Centers of excellence: a medical measurement or marketing myth? Med Group Manage J. 1996;43:66, 68, 70 passim.
46. HSR&D Centers of Excellence. United States Department of Veterans Affairs. Available at: http://www.hsrd.research.va.gov/centers/centers of excellence. cfm. Accessed February 16, 2011.
47. National Center on Minority Health and Health Disparities. Department of Health and Human Services. Available at: http://www.nimhd.nih.gov/our programs/centerOfExcellence.asp. Accessed February 16, 2011.
48. Defense Centers of Excellence for Psychological Health & Traumatic Brain Injury. United States of America Department of Defense. Available at: http://www.dcoe.health.mil/. Accessed Feb 16, 2011.
49. ASMBS Centers of Excellence Bariatric Surgery. American Society for Metabolic&Bariatric Surgery.Available at: http://www.asmbs.org/Newsite07/ resources/asmbs coe.htm. Accessed February 16, 2011.
50. Womenshealth.gov. National Centers of Excellence in Women's Health, U.S. Department of Health & Human Services. Available at: http://www. womenshealth.gov/archive/owh/multidisciplinary/. Accessed February 16, 2011.
51. Birkmeyer NJ, Dimick JB, Share D, et al. Hospital complication rates with bariatric surgery in Michigan. JAMA. 2010;304:435-442.
52. Livingston EH. Bariatric surgery outcomes at designated centers of excellence vs nondesignated programs. Arch Surg. 2009;144:319-325; discussion 325.